Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 6,330 KRW
Change Today +270.00 / 4.46%
Volume 142.4K
039860 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:26 AM 04/2/15 All times are local (Market data is delayed by at least 15 minutes).

nanoentek inc (039860) Snapshot

Open
6,100
Previous Close
6,060
Day High
6,330
Day Low
6,000
52 Week High
07/14/14 - 8,180
52 Week Low
12/18/14 - 5,200
Market Cap
142.9B
Average Volume 10 Days
75.8K
EPS TTM
-113.00
Shares Outstanding
22.6M
EX-Date
03/23/07
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NANOENTEK INC (039860)

Related News

No related news articles were found.

nanoentek inc (039860) Related Businessweek News

No Related Businessweek News Found

nanoentek inc (039860) Details

NanoEnTek Inc. engages in the development of various devices for life science research and point-of-care diagnostics in South Korea. It provides life science products, including Juli, an all-in-one real time cell monitoring system; Juli Br, a live cell movie analyzer; EVE, a benchtop counter to measure cell count and viability; ADAM SCC, a raw milk quality control device; Adam MC, an automated cell counter that performs viability and cell counting measurements through the PI staining method of dead-cell staining combined with advanced image analysis; C-Chip, a precision disposable plastic hemocytomer to solve the conventional glass hemocytomer problems; and integrated sample banking systems. The company also offers medical devices comprising FREND systems; and ADAM-rWBC, an analytical device for counting the residual white blood cells in leukoreduced blood products. NanoEnTek Inc. is headquartered in Seoul, South Korea.

nanoentek inc (039860) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanoentek inc (039860) Key Developments

NanoEnTek Inc., Annual General Meeting, Mar 27, 2015

NanoEnTek Inc., Annual General Meeting, Mar 27, 2015., at 09:30 Korea Standard Time.

NanoEnTek Inc., Annual General Meeting, Mar 28, 2014

NanoEnTek Inc., Annual General Meeting, Mar 28, 2014., at 09:30 Korea Standard Time. Location: Seoul Guro digital 273 Ace Twin Tower 2 occupied one floor seminar room. Agenda: To approve the separate and consolidated financial statements; to approve to change the constitution; to elect directors; to appoint the auditor; and to approve directors' remuneration limits.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
039860:KS 6,330.00 KRW +270.00

039860 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 039860.
View Industry Companies
 

Industry Analysis

039860

Industry Average

Valuation 039860 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.9x
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOENTEK INC, please visit www.nanoentek.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.